OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Hovione has announced that Jean-Luc Herbeaux will take over for Guy Villax as CEO on April 1, 2022.
Hovione announced on Feb. 25, 2022 that Jean-Luc Herbeaux, Hovione’s current chief operating officer (COO), will be their next CEO. Herbeaux will take over for Guy Villax, Hovione’s CEO for the past 25 years, on April 1, 2022.
According to a company press release, Hovione grew tenfold over the course of Villax’s tenure. The company has over 2000 employees and has four production sites in three regions. Going forward, Villax will now serve as a member of the board and shareholder.
“It has been a privilege and honor to lead Hovione over the last decades. I have seen this company, founded by my parents, growing, evolving and constantly re-inventing itself,” said Villax in the press release. “Dr. Herbeaux joined Hovione nearly two years ago as COO and from day [one] brought change and contributed to financial and business successes. We have worked together both on the strategy, which will take Hovione to the next level, and on making this transition smooth.”
Before joining Hovione in 2020, Herbeaux held multiple high-level positions at Evonik.
“I am honored to be entrusted with the role of Hovione’s CEO, and I am deeply motivated to lead this team of talented professionals,” said Herbeaux in the press release. “Building on Guy Villax´s legacy of innovation and customer intimacy, we will continue to work to drive long-term growth for both ourselves and our customers maintaining the Hovione values.”